23 May 2013
Keywords: therakos/icn, trial, protocol, approved, uvar, photopheresis, device
Article | 29 March 1993
- A trial of Therakos/ICN's Uvar photopheresis device in combination
with Oxsoralen (methoxsalen) for the treatment of scleroderma has been
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 October 1992
22 May 2013
© 2013 thepharmaletter.com